Podcast appearances and mentions of daniel lucey

This meeting of the Commission took place on January 14, 2015. See here for more information on this event. Panel One: Biological Arms Control, Cooperative Threat Reduction, Global Health Security Agenda, and Quarantine Dr. David R. Franz (via internet video) Dr. Dan Gerstein Dr. Beth Cameron Dr. Mike Stoto Working Lunch: First Responder Protection  Dr. William Raub Panel Two: Biosecurity, the Select Agent Program, and Synthetic Biology Dr. Timothy Lu Dr. Tom Ksiazek Panel Three: Resilience, Biodeterrence, First Responder Vaccination, and Agricultural Defense Dr. Jeff Levi Mr. Bruce Miller Mr. Mark Landahl Dr. Curt Mann Panel Four: Insights on Ebola and Pandemic Influenza Response Dr. Robin Robinson Dr. Monique Mansoura Dr. Daniel Lucey  

Many experts don't think Corona virus started in The Wuhan Market. Some think it was a virus that escaped from a lab in Wuhan run now by the military. Others think it had "natural" origins but broke out months before the end of 2019.And. we need those answers to understand where the next pandemic could start, as well as the increased dangers of a biological attack.On this Back Story Dana Lewis talks to Former Deputy Sec. of Defense Andy Weber, and virus hunter Dr. Daniel Lucey.

Featured interview: COVID-19 mutations found in Minks and implications for further spread -덴마크 내 밍크가 만든 신종 코로나19 변종 Guest: Dr. Daniel Lucey, Professor of Medicine-Infectious Diseases, Georgetown University Medical Center

Raheem Kassam, Jack Maxey, and Greg Manz are joined by Steve Bannon to discuss the latest on the coronavirus pandemic as the administration sets up the war plan to take on the CCP. Calling in is John Merrifield to discuss the America's current crushing debt. Also calling in is Daniel Lucey to discuss the questions that need to be asked about the origins of the virus.

Raheem Kassam, Jack Maxey, and Greg Manz are joined by Steve Bannon to discuss the latest on the coronavirus pandemic as the administration sets up the war plan to take on the CCP. Calling in is John Merrifield to discuss the America's current crushing debt. Also calling in is Daniel Lucey to discuss the questions that need to be asked about the origins of the virus.

Two global health experts, Daniel Lucey, MD, MPH, and George Anesi, MD, MSCE, MBE, discuss the most up to date information regarding COVID-19. Listen now to learn about preparedness and how this pandemic can specifically impact patients with asthma, allergies and immune deficiency.

IDSA’s Coronavirus Expert Panel, Dr. Daniel Lucey, FIDSA, Dr. Matthew Zahn, and CDC's Dr. Tim Uyeki & Dr. Satish Pillai share what you need to know about COVID-19. 

Wuhan City, China has been a focus for infectious disease and public health experts over the past month due to a pneumonia outbreak where the etiology is not quite clear. News keeps trickling in on this outbreak, but there is still a lot unknown. Hoping to shed some light on this outbreak today is Daniel Lucey, MD, MPH. Dr Lucey is a Senior Scholar with the O'Neill Institute for National and Global Health Law. He is also an adjunct Professor of Medicine-Infectious Diseases at Georgetown University Medical Center.

A conversation with Dr. Daniel Lucey comparing and contrasting the current Ebola epidemic in the North Kivu region of the Democratic Republic of the Congo and the 2014 West Africa Ebola epidemic. We touch on advances made in vaccines, diagnostics, treatments, and how the lessons learned from the West Africa epidemic are being applied, as well as the challenges faced by a region in conflict. Show Notes: [WHO | Stories of Ebola survivors](https://www.who.int/features/2014/ebola-survivor-stories/en/) [2014-2016 Ebola Outbreak in West Africa | History | Ebola (Ebola Virus Disease) | CDC](https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html) [An Epidemic of Suspicion — Ebola and Violence in the DRC | NEJM](https://www.nejm.org/doi/full/10.1056/NEJMp1902682) Congolese Ministry of Health Twitter: @MinSanteRDC https://www.who.int/emergencies/crises/cod/drc-ebola-srp-v20190219-fr.pdf?ua=1 (National Plan to Combat Ebola) [Digitalcongo.net | Le ministre de la Santé dresse la situation sur l’évolution de l’épidémie à virus Ebola dans les provinces du Nord-Kivu et de l’Ituri](https://www.digitalcongo.net/article/5c825c724813c5000431e377/) [WHO | Ebola virus disease – Democratic Republic of the Congo](https://www.who.int/csr/don/7-march-2019-ebola-drc/en/) [WHO expresses concern over damage to Ebola treatment facilities in the Democratic Republic of the Congo | WHO | Regional Office for Africa](https://www.afro.who.int/media-centre/statements-commentaries/who-expresses-concern-over-damage-ebola-treatment-facilities) [Statement on the October 2018 meeting of the IHR Emergency Committee on the Ebola virus disease outbreak in the Democratic Republic of the Congo](https://www.who.int/news-room/detail/17-10-2018-statement-on-the-meeting-of-the-ihr-emergency-committee-on-the-ebola-outbreak-in-drc) [MSF warns of DRC Ebola response losing upper hand | CIDRAP](http://www.cidrap.umn.edu/news-perspective/2019/03/msf-warns-drc-ebola-response-losing-upper-hand) [Democratic Republic of Congo: Ebola Virus Disease - External Situation Report 31 - Democratic Republic of the Congo | ReliefWeb](https://reliefweb.int/report/democratic-republic-congo/democratic-republic-congo-ebola-virus-disease-external-situation-46) https://www.who.int/immunization/interim_ebola_recommendations_feb_2019.pdf?ua=1

In 2016, the World Health Organization announced that a single full dose of yellow fever vaccine would provide lifelong protection from the virus. However, due to global shortages and complicated production requirements, there has not been sufficient supply to meet the demands of recent outbreaks. Angola and the Democratic Republic of Congo in 2016 and now Brazil in 2018 have turned to using fractional doses, or about 1/5 of a full dose, as a stopgap measure—these diluted doses are only known to offer one year of protection against the virus. In this episode of Take as Directed, Daniel Lucey, a senior scholar with the O’Neill Institute for National and Global Health Law at Georgetown University, joins us to discuss the threat of yellow fever, our lack of preparedness, and the potential for a significant outbreak in Asia.   Hosted by Steve Morrison. Produced by Alex Bush. Edited by Ribka Gemilangsari.

Nikolai DiPippa, Clinton School Director of Public Programs, sat down with Daniel Lucey, a physician trained in infectious diseases and public health. He’s taught eleven years at Georgetown on global emerging infectious diseases. He’s travelled widely in Asia and the Middle East to exchange information regarding infectious diseases such as SARS, HIV and anthrax.

April 7, 2015. Daniel Lucey spoke about his work with Ebola in Sierra Leone and Liberia. Speaker Biography: Daniel Lucey is an adjunct professor in the Department of Microbiology and Immunology at Georgetown University School of Medicine and an adjunct professor of law at Georgetown University Law Center. He is a member of Doctors Without Borders. For transcript, captions, and more information, visit http://www.loc.gov/today/cyberlc/feature_wdesc.php?rec=6755

From your local bus route to international air travel, infectious diseases can spread across the globe in a matter of hours. In this video podcast episode filmed at the Koshland Science Museum in Washington, D.C., Stephen Eubank from the Virginia Bioinformatics Institute of Virginia Tech and Daniel Lucey from Georgetown University discuss the role of transportation in the spread of disease and examine the effectiveness of various measures to curb transmission. Stephen Eubank, Ph.D., is a project director at the Network Dynamics and Simulation Science Laboratory at the Virginia Bioinformatics Institute of Virginia Tech. His research focuses on modeling and simulating the spread of disease and regional transportation, and the analysis of complex systems. Daniel Lucey, M.D., M.P.H., is an adjunct professor in the Department of Microbiology and Immunology at Georgetown University, where he is co-director of the master of science program in biohazardous threat agents and emerging infectious diseases. In recent years, his teaching focus has been on SARS, avian flu, and the threat of pandemic human influenza. Resources Learn more about infectious diseases at http://www.koshland-science-museum.org/exhib_infectious/index.jsp Transportation Research Board of the National Academies http://www.trb.org/default.asp Pandemic Flu and Travel http://www.pandemicflu.gov/travel/index.html